Bioport posts:

Tim Alefantis vaccine scientist and cousin of James A, the H1N1 virus, Bioport, and Dynport of Dyncorp. Why is the child trafficking industry and public health industry seemingly so closely connected?

Before teaming up with Dyncorp, Porton (UK) had created a US branch of their company know as BioPort. In the 1990s it had become one of a small minority of companies with the ability to produce an anthrax vaccine.

After three years of getting bailed out by the Defense Department, BioPort could be poised to make a fortune -- as its CEO Fuad El-Hibri did working with the British seller of anthrax vaccine, Porton International, during the Gulf War a decade ago.

The mania for privatization in Margaret Thatcher's England made it a great place for entrepreneurs like El-Hibri. In the 1980s, an El-Hibri acquaintance named Zsolt Harsyani, an American Ph.D. in genetics who had spearheaded an early report on biotechnology for the U.S. Office of Technology Assessment, became involved in what would become in its time the largest private biotechnology firm in the world, Porton International. Porton got the rights to sell vaccines and other products developed by the U.K.-government run laboratory, the Centre for Applied Microbiology and Research (CAMR), on commercial markets. CAMR had done the early research into products like botulinum toxin, or botox, a bacterium that can be injected to stop spasms (as well as prevent wrinkles, its most popular use in the U.S., at least until now) and anthrax vaccine.

Very interesting comment from @swordfish69

You should triangulate minor H1N1 outbreaks with global elections, that's how I figured out that the 2010 Ukrainian Swine Flu outbreak was possibly a setup to pressure the Yanukovych gov (who manafort was helping get elected).

Well, there's another election on the horizon.

El-Hibri Foundation https://www.elhibrifoundation.org/about/board_of_trustees

The El-Hibri Foundation (EHF) is a philanthropic organization that empowers and equips Muslim leaders and their allies to build thriving, inclusive communities. EHF makes grants and implements innovative programs to provide resources and skills, forge collaborative relationships, and increase inclusion of and within American Muslim communities.

https://www.elhibrifoundation.org/about/background

The El-Hibri family established the El-Hibri Foundation in 2001. It is a tribute to the memory of Ibrahim El-Hibri (1936-2007), who made a substantial gift to the Foundation to continue his family’s long commitment to helping the less fortunate and promoting interfaith understanding.

A successful businessman and devout Muslim, Ibrahim El-Hibri believed in the commonality of the three monotheistic religions—Christianity, Judaism and Islam—and stressed their similarities instead of their differences. His focus on tolerance, civic engagement and social responsibility were expressed in many philanthropic endeavors.

How Big Pharma Is About To Profit Again Off Crisis https://www.mintpressnews.com/how-emergent-solutions-plans-corner-covid-19-cure-market/266615/

The Michigan Biologic Products Institute (MBPI) had been founded in 1926 by the State to serve the vaccination needs of its largely rural population, many of whom worked on farms and required inoculation against naturally occurring anthrax spores and rabies. By the 1980s, the Institute stood alone as the only anthrax vaccine manufacturer in the U.S. after 1970s-era regulations had driven most private vaccine manufacturers out of business. MBPI’s anthrax vaccine was known as Anthrax Vaccine Adsorbed (AVA) or BioThrax.

..Emergent’s history of corruption and profiteering has in no way prevented them from cashing in on the COVID-19 global health crisis. On March 10, Emergent announced a partnership with Novavax to produce a COVID-19 vaccine, a vaccine also backed by the Bill Gates-backed Coalition for Epidemic Preparedness Innovations (CEPI). CEPI had previously partnered with Emergent Biosolutions, giving them over $60 million in 2018. Emergent further expanded its partnership with NovaVax on March 31.

NanoBio Announces Corporate Name Change to BlueWillow Biologics and Closes $10M Series A Financing https://www.bluewillow.com/nanobio-announces-corporate-name-change-to-bluewillow-biologics-and-closes-10m-series-a-financing/

The name BlueWillow Biologics is a nod to the company’s roots as well as a commitment to the company’s future as a developer of the next generation of vaccines. “Blue” is a subtle reference to the University of Michigan, where the company’s nanotechnology was discovered. While “Willow” refers to willow trees, which are known to have deep, strong roots and large, protective branches.

“The NIH, Bill & Melinda Gates Foundation, State of Michigan, Michigan Nanotechnology Institute for Medicine and Biological Sciences and the University of Michigan Technology Transfer Office have been instrumental in the advancement of BlueWillow’s intranasal vaccine platform,” Peralta said. “We are very grateful to each of these partners, as well as our core investors, for their support, guidance and investment in BlueWillow’s promising future.”

In 1998, Speywood Pharmaceuticals Ltd of the UK, changed its name to Ipsen Ltd to reflect the name of its parent company Beaufour Ipsen.

https://en.wikipedia.org/wiki/Ipsen

Ipsen is a French pharmaceutical company headquartered in Paris, France...The Beaufour family, which ranks as the 42nd richest family in France, still owns 57% of its shares and 73% of its voting rights,[2]:217 and two of its members, Anne Beaufour and Henri Beaufour, sit on its board of directors.[

In 1983, Ipsen founded the Ipsen Foundation (Fondation Ipsen) with the help of the Fondation de France to track progress in biomedical research.[11][12] It is headquartered in Boulogne-Billancourt.[11][12] It has organised 64 colloquia, and it has partnered with the World Health Organization, the Fondation Nationale de Gérontologie, Harvard University, the Salk Institute for Biological Studies, the Massachusetts General Hospital, and the academic journals Nature and Cell.

Non-executive chairman, Marc de Garidel https://en.wikipedia.org/wiki/Marc_de_Garidel

He is President and spokesperson for G5 santé, a lobbying group for French pharmaceutical companies, including BioMérieux, Guerbet, Ipsen, the Laboratoire français du Fractionnement et des Biotechnologies, Laboratoires Pierre Fabre, Sanofi, Stallergenes and Laboratoires Théa.

The Board of Directors of Ipsen has appointed David Meek as Chief Executive Officer, effective July 18, 2016.[2] On this date, Marc de Garidel will assume the role of non-executive chairman and will continue to serve the Board of Directors through his deep industry expertise. In addition, Marc de Garidel will advise Mayroy, the Ipsen controlling holding company

Speywood connections with UK tainted blood scandal https://en.wikipedia.org/wiki/Contaminated_blood_scandal_in_the_United_Kingdom

The Contaminated Blood Scandal in the United Kingdom arose when at least 3,891 people, most of whom suffered from haemophilia, became infected with hepatitis C of whom 1,243 were also infected with HIV, the virus that leads to acquired immune deficiency syndrome (AIDS), as a result of receiving contaminated clotting factor products supplied by the National Health Service (NHS) in the 1970s and 1980s. As of October 2017 there were at least 1,246 confirmed deaths in the UK of people who were killed by the clotting agents Factor VIII & Factor IX and the viruses they transmitted. Some have estimated that the total number of those who have died could be as high as 2,400 though exact figures are not known...

Plasma donations could be collected using a process called plasmapheresis. In addition to NHS derived Factor produced by Bio Products Laboratory (BPL), manufacturers that supplied clotting factor products to the UK during the mid-1970s and 1980s included Abbott (Profilate), Armour Pharmaceuticals (Factorate), Bayer-owned Cutter (Koate), Baxter International-owned Travenol/Hyland (Hemofil/Interhem), Immuno (Kryobulin) and Speywood (Humanate).

Philip Hammond https://en.wikipedia.org/wiki/Philip_Hammond

Hammond joined the medical equipment manufacturers Speywood Laboratories Ltd in 1977, becoming a director of Speywood Medical Limited in 1981.[13] He left in 1983 and, from 1984, served as a director in Castlemead Ltd.

Tained blood scandal timeline https://www.taintedblood.info/tb/timeline/

we discover that highly purified genetically-engineered Factor VIIIc was already being produced by a team at the Royal Free Hospital and that Genentech owned the RF method. We also read that Speywood signed a collaboration agreement with Genentech in relation to genetic engineering of FVIII.

https://invidio.us/watch?v=eXnsTisOLEw :

We Were Right On Target Over Three Years Ago On The Virus Vaccine Game Of DynPort - YouTube

This has been an automated message.

2007 article: Emergent BioSolutions Completes First Delivery of BioThrax(R) (Anthrax Vaccine Adsorbed) to The Department of Health and Human Services under New Contract https://investors.emergentbiosolutions.com/news-releases/news-release-details/emergent-biosolutions-completes-first-delivery-biothraxr-anthrax?field_nir_news_date_value[min]=